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Abstract Flavonoids are present in many plants including edible
fruits and vegetables. Recently, many of the biological activities
of flavonoids have been elucidated. Flavone is a well known
flavonoid, and many of its derivatives have been shown to have
anti-proliferative effects on several cancer cells. We report here
that flavone can effectively inhibit the cell growth of human lung
adenocarcinoma A549 cells in a dose-dependent manner, and 100
WM flavone causes cell cycle arrest at the G1 phase. As a
mechanism underlying the cell cycle arrest, flavone markedly
increases the mRNA and protein levels of a universal inhibitor of
cyclin-dependent kinase, p21/WAF1, and inhibits phosphoryla-
tion of retinoblastoma (RB) protein. Although A549 cells possess
wild-type p53, flavone does not induce the p53 protein, suggesting
that p21/WAF1 induction is p53-independent. In addition, 100
WM flavone significantly increases the promoter activity of the
p21/WAF1 gene by 5-fold. These results suggest that the G1
phase arrest by flavone is due to p53-independent transcriptional
induction of the p21/WAF1 gene and the subsequent dephos-
phorylation of RB protein.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Flavonoids, ubiquitously occurring and widely consumed
metabolites of plants, constitute some of the active compo-
nents in vegetables and fruits. People consume about 1 g of
£avonoids per day in the common diet [1]. Many types of
£avonoids prevent or inhibit cancer development in vivo [2]
and inhibit cell growth in vitro [3^6]. Flavone is a well known
£avonoid and is present in many cereal grains and wheat [7].
Flavone has a basic structure, and many of its derivatives
have been reported to have strong anti-cancer e¡ects in hu-
man breast cancer cells [8] and in transplanted colon adeno-
carcinoma [9]. Because of these e¡ects, it is expected that
£avone may be used as an anti-cancer drug.
p21/WAF1 protein inhibits the activities of various cyclin-
dependent kinases [10^12], and inhibits the phosphorylation
of retinoblastoma (RB) protein, thereby inhibiting the G1-S
phase transition [10,13]. It is also well known that the p21/
WAF1 gene is transcriptionally activated by wild-type p53
protein [14], suggesting that p21/WAF1 could play a key
role as a downstream mediator of the p53-induced cell growth
arrest.
In our previous study, we found that £avone inhibits cell
growth in vitro and causes G1 phase arrest in a human gastric
cancer cell line, HGC-27 [5]. However, the mechanism of G1
arrest by £avone is still unclear. To clarify the mechanism of
the anti-proliferative e¡ect of £avone, we determined whether
£avone can induce the expression of the p21/WAF1 gene, the
product of which is involved in G1 phase arrest, and stimulate
the activity of the p21/WAF1 gene promoter in a human lung
cancer cell line A549.
2. Materials and methods
2.1. Reagent
Flavone was purchased from Nacalai Tesque, dissolved in dimethyl
sulfoxide (DMSO) and diluted to the respective ¢nal concentrations in
each culture dish.
2.2. Cell culture and cell growth study
A549 (a human lung adenocarcinoma cell line) cells were cultured
in Dulbecco’s modi¢ed Eagle’s medium (DMEM) (Nissui Pharma-
ceutical, Tokyo, Japan) containing 10% fetal bovine serum and incu-
bated at 37‡C in a humidi¢ed atmosphere of 5% CO2 in air. A549
cells were seeded at a density of 2U104 cells/2 ml of medium in 35-
mm diameter dishes. Various concentrations of £avone were added to
cells 24 h after cell seeding. Twenty-four hours, 48 and 72 h after the
addition of £avone or DMSO, the number of cells was counted by the
Trypan-blue dye exclusion test. This cell growth study was carried out
in triplicate and repeated at least three times.
2.3. Analysis of cell cycle progression
Cells were plated at a density of 1U105 cells/10 ml of medium in
100-mm diameter dishes. Flavone was added to cells 24 h after cell
seeding. Twenty-four hours after the addition of £avone, cells were
removed from the culture dishes by trypsinization and centrifugation.
After washing with PBS, cells were suspended in PBS containing 0.1%
Triton X-100 to prepare nuclei. After the suspension was ¢ltered
through a 50-mm nylon mesh, 0.1% RNase and 50 mg/ml of propi-
dium iodide were added. DNA contents in stained nuclei were ana-
lyzed with FACScan (Becton Dickinson). A suspension of 1U104 cells
was analyzed for each DNA histogram. The number of stained nuclei
in each phase was measured using the S-¢t program in the FACScan
[15].
2.4. Northern blot analysis
Cells were plated at a density of 4U105 cells/10 ml of medium in
100-mm diameter dishes. Flavone was added to cells 24 h after cell
seeding. Twenty-four hours after the addition of £avone, cells were
washed twice in PBS and total RNA was isolated from cells using the
TRIzol RNA isolation kit (Gibco-BRL), and 10 Wg of total RNA per
lane was subjected to Northern blot analysis. The p21/WAF1 cDNA
as the probe was isolated from the pCEP-WAF1 plasmid (a kind gift
from Dr. B. Vogelstein), by digesting with NotI. Northern blot anal-
ysis was performed using standard methods. To con¢rm the amount
and quality of RNAs loaded in each lane, RNAs were stained with
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ethidium bromide (EtBr). The mRNA level was determined using the
bio-imaging analyzer BAS 2000 (Fujix).
2.5. Western blot analysis
Cells were plated at a density of 4U105 cells/10 ml of medium in
100-mm diameter dishes. Flavone was added to cells 24 h after cell
seeding. Twenty-four hours after the addition of £avone, cells were
washed twice in PBS, resuspended in sample bu¡er (10% glycerol, 1%
SDS, 5% mercaptoethanol, 50 mM Tris-HCl (pH 6.8) and 0.025%
BPB), and the samples were boiled for 5 min. Equivalent amounts
of total protein from each sample were run on 12% SDS-polyacryl-
amide gels and blotted onto a nitrocellulose ¢lter. The ¢lter was pre-
treated with PBS containing 0.2% Tween 20 and 4% dry milk, and
incubated overnight at 4 with anti-human p21/WAF1 antibody in the
same bu¡er. The ¢lter was washed in washing bu¡er containing PBS
and 0.2% Tween 20, soaked for 1 h with horseradish peroxidase-
linked anti-mouse Ig, and then washed in washing bu¡er and ¢nally
in PBS only. Detection was achieved using an enhanced chemilumi-
nescence kit (Amersham Life Science) with a 2-min exposure of the
autoradiograph.
2.6. Transient transfection and luciferase assay
A549 cells were transfected using the calcium phosphate coprecipi-
tation technique. A549 cells were inoculated at a density of 4U105
cells/5 ml of DMEM in 100-mm diameter dishes. After 24 h, 4 Wg of
wild-type p21/WAF1-luciferase reporter plasmid, WWP-Luc, in a cal-
cium phosphate precipitate was used for transfection, and added to
the medium. Eight hours after the transfection, the medium was
changed. Twenty-four hours after the transfection, £avone was added,
and 24 h after the addition of £avone, cell lysates were collected for a
luciferase assay. The luciferase activities of the cell lysates were meas-
ured as described previously [16]. Luciferase activities were normalized
by the amount of protein in the cell lysates. All the luciferase assays
were carried out at least in triplicate, and the experiments were re-
peated at least three times.
3. Results
3.1. Flavone inhibits the proliferation of A549 cells
We ¢rst investigated the e¡ect of £avone on the prolifera-
tion of human lung adenocarcinoma A549 cells using three
concentrations (30, 60 and 100 WM) of £avone. Equivalent
volumes of DMSO were used as controls. Twenty-four, 48
and 72 h after the addition of £avone, the growth inhibitory
e¡ect of £avone was observed in a dose-dependent manner
and 100 WM £avone had a cytostatic e¡ect on A549 cells.
On day 4, the growth of cells was inhibited to 40.9, 23.6
and 10.6% of the control level by 30, 60 and 100 WM £avone,
respectively (Fig. 1).
3.2. Flavone arrests A549 cells in the G1 phase of the cell cycle
The e¡ect of £avone on the cell cycle progression of A549
cells was determined by £ow cytometric analysis 24 h after its
addition. DNA histograms in Fig. 2 show that £avone in-
creased the population of G1 phase cells compared with the
control. Using the cytostatic dose of £avone (100 WM), the
percentage of cells in the G1 phase increased from 47% to
72%, and that in the S phase decreased from 44% to 21%.
These data demonstrate that £avone arrests the cell cycle of
A549 cells at the G1 phase.
3.3. Flavone increases p21/WAF1 mRNA level
To investigate whether the cyclin-dependent kinase inhibi-
tor p21/WAF1 is involved in the £avone-induced growth ar-
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Fig. 1. E¡ect of £avone on the proliferation of A549 cells. Cells
were seeded at a density of 2U104 cells/2 ml of DMEM per dish on
day 0. DMSO or various concentrations of £avone were added to
the cultures on day 1 (E, DMSO; 7, 30 WM £avone; a, 60 WM £a-
vone; O, 100 WM £avone). The numbers of viable cells were
counted on days 2, 3 and 4 by the Trypan-blue dye exclusion meth-
od. Representative data from three independent experiments are
shown.
Fig. 2. DNA histograms of the cell cycle in A549 cells. A549 cells
were seeded at a density of 1U105 cells/10 ml of DMEM per dish.
DMSO or 100 WM £avone was added to the cells 24 h after cell
seeding. The cell cycle stage was analyzed 24 h after the addition of
the drug.
Fig. 3. Induction of p21/WAF1 mRNA by £avone in A549 cells.
A549 cells were seeded at a density of 4U105 cells/10 ml of DMEM
per dish. A: Various concentrations of £avone or equivalent volume
of DMSO was added to the cells 24 h after cell seeding. Total
RNA was collected 24 h after the drug addition and Northern blot
analysis was carried out. B: Sixty WM £avone or an equivalent vol-
ume of DMSO was added to the cells 24 h after cell seeding. Total
RNA was collected at the indicated times after the drug addition
and Northern blot analysis was carried out.
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rest of A549 cells, three concentrations of £avone (30, 60 and
100 WM) and equivalent volume of DMSO were added to
A549 cells, and p21/WAF1 mRNA expression was assayed
by Northern blot analysis. Marked induction of p21/WAF1
mRNA was observed in a dose-dependent manner following a
24-h exposure to £avone (Fig. 3A). This is consistent with the
result that £avone inhibited the growth of A549 cells dose-
dependently. In the time course study, the p21/WAF1 mRNA
level of A549 cells started to increase 3 h after treatment with
100 WM £avone, and it continued until 36 h after exposure
(Fig. 3B).
3.4. Flavone induces p21/WAF1 protein in A549 cells
We clari¢ed whether the p21/WAF1 protein could also be
induced by treatment of A549 cells with £avone. Thirty-six
hours after the addition of £avone (30, 60 and 100 WM), p21/
WAF1 protein was induced in a dose-dependent manner (Fig.
4A). In the time course study, treatment with 100 WM £avone
induced p21/WAF1 protein 12 h after exposure, and a strong
induction of p21/WAF1 protein was observed from 24 h to 48
h after exposure (Fig. 4B). We investigated the induction in
A549 cells of another CDK inhibitor, p27, but only slight
induction was observed upon treatment with £avone (data
not shown). A549 cells lack the CDK inhibitor, p16. There-
fore, p21/WAF1 gene induction could be the major cause of
G1 phase arrest in A549 cells.
3.5. Flavone induces p21/WAF1 in a p53-independent manner
The p21/WAF1 gene was ¢rst characterized as a p53-de-
pendent gene [14]. As A549 is a p53 positive cell line [17],
we investigated the induction of p53 protein in A549 cells to
clarify whether p21/WAF1 induction by £avone is p53-de-
pendent. Surprisingly, treatment with 100 WM £avone did
not change or slightly decreased the p53 level (Fig. 5A,B),
suggesting that p21/WAF1 induction by £avone in A549 cells
is p53-independent.
3.6. Flavone inhibits phosphorylation of RB protein
p21/WAF1 is known to inhibit cyclin-dependent kinase ac-
tivity and the subsequent dephosphorylation of RB protein
arrests the cell cycle at the G1 phase. We clari¢ed whether
£avone can change the phosphorylation status of the RB pro-
tein using Western blotting. When A549 cells were exposed to
100 WM £avone for 12^48 h, the majority of the RB protein
molecules was converted to the hypophosphorylated form
(Fig. 5C). These results suggest that the G1 phase arrest
caused by £avone is due to dephosphorylation of the RB
protein.
3.7. p21/WAF1 promoter activation by £avone
To determine whether p21/WAF1 mRNA induction is
mediated through p21/WAF1 gene promoter activation, we
clari¢ed whether £avone can stimulate the activity of the pro-
moter of the p21/WAF1 gene using transient transfection. A
24-h exposure to 30, 60 and 100 WM £avone increased the
p21/WAF1 promoter activity in a dose-dependent manner
up to 5-fold compared with the untreated control (Fig. 6).
Our Western blotting data suggests that the p21/WAF1 in-
duction by £avone is p53-independent. Therefore, £avone
might be able to respond to a speci¢c region of other than
the p53 binding sites.
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Fig. 5. Induction of p53 protein by £avone in A549 cells. A: Vari-
ous doses of £avone (30 WM, 60 WM, and 100 WM) or DMSO was
added to dishes. Twenty-four hours after the drug addition, total
protein was collected and Western blot analysis was carried out. B:
One hundred WM £avone or an equivalent volume of DMSO was
added to the cells 24 h after cell seeding. Total protein was collected
at the indicated times after the drug addition and Western blot
analysis was carried out. C: Dephosphorylation of RB protein by
£avone in A549 cells. One hundred WM £avone or an equivalent
volume of DMSO was added to the cells. Total protein was col-
lected at the indicated times after the drug addition and Western
blot analysis was carried out.
Fig. 6. Stimulation of p21/WAF1 promoter activity in A549 cells by
treatment with £avone. A549 cells were transiently transfected with
the wild-type p21/WAF1-luciferase reporter plasmid, WWP-Luc,
and luciferase activity was measured 24 h after the addition of
DMSO, or 30 WM, 60 WM and 100 WM £avone. Data are shown as
means þ S.D. (n = 3). *P6 0.05.
Fig. 4. Induction of p21/WAF1 protein by £avone in A549 cells.
A549 cells were seeded at a density of 4U105 cells/10 ml of DMEM
per dish. A: Various concentrations of £avone or an equivalent vol-
ume of DMSO was added to the cells 24 h after cell seeding. Total
protein was collected 36 h after the drug addition and Western blot
analysis was carried out. B: One hundred WM £avone or an equiva-
lent volume of DMSO was added to the cells 24 h after cell seeding.
Total protein was collected at the indicated times after the drug ad-
dition and Western blot analysis was carried out.
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4. Discussion
In this study, we showed that £avone arrests the cell cycle
at the G1 phase in A549 cells. In addition, we showed that
£avone induces a cyclin-dependent kinase inhibitor, p21/
WAF1, without increasing the p53 protein level which results
in dephosphorylation of the RB protein which is involved in
the G1 phase arrest. Moreover, £avone stimulates p21/WAF1
gene promoter activity, suggesting that the p21/WAF1 gene
induction is mediated through activation of its promoter in a
p53-independent manner. These results suggest that stimula-
tion of p21/WAF1 gene by £avone causes dephosphorylation
of RB gene product resulting in G1 phase arrest. However, it
cannot be ruled out that £avone might dephosphorylate the
RB protein by a p21/WAF1-independent pathway. In order to
clarify this possibility, more study will be required at the next
step.
Recently, several reports indicate p53-independent regula-
tion of the p21/WAF1 gene. TGF-L [18], phorbol myristate
acetate (PMA) [19], okadaic acid [19], butyrate [20] and tri-
chostatin A [21] stimulate the p21/WAF1 gene promoter
through Sp1 sites in the promoter. In addition, transcription
factors such as signal transducers and activators of transcrip-
tion (STAT) protein [22], vitamin D3 receptor [23] and C/
EBPL [24] act via their speci¢c binding sites in the p21/
WAF1 promoter. We investigated the responsive region of
£avone, and found that it was included in the 124-base pair
region upstream from the transcription start site, in which two
p53-binding sites are not located (data not shown). In this
region there are six Sp1 sites and a TATA box [20] but no
p53-binding site, which is consistent with our data that p21/
WAF1 induction by £avone is p53-independent.
Recently, £avopiridol, a derivative of £avone, was reported
to cause G1 arrest in a p53-independent manner in a human
breast carcinoma cell line MCF-7 [25]. Flavopiridol binds di-
rectly to cyclin-dependent kinases CDK2 and CDK4, thereby
inhibiting their activities [26], and arrests the cell cycle in the
G1 phase. In our study, the induction of the CDK inhibitor
p21/WAF1 by £avone was suggested to be the cause of G1
phase arrest. However, the data for £avopiridol suggests the
possibility that £avone might directly bind to CDKs.
In summary, our study demonstrates that £avone, which is
a well known £avonoid, can arrest the cell cycle in the G1
phase in A549 cells possibly through activation of the p21/
WAF1 gene promoter and induction of p21/WAF1 protein in
a p53-independent manner. Recently, we proposed a novel
strategy for chemotherapy or chemoprevention which we
termed ‘gene-regulating chemotherapy or chemoprevention’
[20,27]. This strategy is to activate growth inhibitory genes
using several agents. Our present study suggests that £avone
may be one candidate drug for use in gene-regulating chemo-
therapy or chemoprevention.
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